Podcasts

This episode highlights key DSCSA updates in 2026, T3 documentation going forward, and many more developments surrounding the law.

With a 7-year target date, the FDA is moving away from 10-digit NDCs and toward a universal 12-digit format.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Kami Dixon, MD, MA, to discuss the racial disparities across women’s health in the US.

This episode explores the gaps between pharmacy leaders and the communities, and patients, that they serve.

With workforce and work-life balance issues plaguing pharmacy, the newly introduced hybrid pharmacist role is creating innovation across the greater pharmacy industry.

Episode 9 dives into the landscape of obesity pharmacotherapy, detailing current therapies, clinical updates, future pipelines, and more.

With a slew of new GLP-1 indications approved in recent history, researchers and experts are now diving into their use in treating substance use disorders.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Emily Hoffins, MS, PhD, postdoctoral researcher in the SCRPTS Lab at the University of Illinois Chicago Retzky College of Pharmacy.

Amid recent comments from FDA Commissioner Marty Makary, MD, MPH, that “everything should be OTC,” Mark Garofoli, PharmD, BCGP, CPE, CTTS, helps pharmacists understand what lies ahead.

In a bonus episode of the Over the Counter podcast, William A. Bryson, PharmD, joined to help celebrate Diabetes Alert Day—recognized annually on the fourth Tuesday in March.

This episode highlights the landmark FTC settlement with Express Scripts and what independent pharmacies and plan sponsors can expect going forward.

With ongoing concerns about the safety and formulation of compounded GLP-1s, Annie Lambert, PharmD, BCSCP, added her expert insights into the recent crackdown of these products.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Paul Weidle, PharmD, MPH, to discuss HIV care among women and girls.

With drug shortages continuing to disrupt patient care and pharmacy operations, Lani Bertrand breaks down how AI and automation are reshaping the way pharmacies respond to supply chain disruptions.

This episode explores a specific generalization within pharmacy practice that leaders should actively avoid while simultaneously looking toward overcoming key hurdles affecting team members.

With a key exemption under DSCSA expiring at the end of the year, Matt Sample from Cencora helps pharmacies understand the tools and processes they need now to best comply with the law.

Episode 8 explores the real-world evidence, clinical trial data, and overall application of finerenone for pharmacists and their patients.

With patients and pharmacists existing in new territories since the COVID-19 pandemic, at-home diagnostic testing has come a long way in improving the potential for convenient access to care.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Mohammad Al Numan, BS, MS, a 2025-27 University of Illinois Chicago/Takeda Fellow in Health Economics and Outcomes Research.

With the federal government continuing its reconsideration of vaccine guidelines in the US, Jeff Goad, PharmD, MPH, explains what it means for community pharmacies.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, chats with Laney Poye, the director of marketing and communications at the Preeclampsia Foundation.

As the pharmacy industry seemingly transforms in real-time, expert pharmacists and digital health experts explain how DTP models are paving a new path for drug distribution.

This episode explores the “uphill climb” that many leaders in the modern pharmacy landscape experience and how experts like our hosts are navigating this challenge.

With President Trump’s signing of HR 7148, experts are now racing to get a grasp on the monumental shifts in pharmacy that will stem from this new legislation.

Episode 7 dives into new standards of care from the American Diabetes Association and what updates are most important for pharmacists.

This episode explores important insights on PBM reform and what pharmacies can look out for throughout 2026.

As more prescription drugs move to OTC, the pharmacist’s role in their communities are continuing to shift as well.

With unprecedented changes to Medicare Part D plans at the top of the year, experts from ASCP help pharmacy businesses understand key provisions under the IRA.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, meets with Kristen Sobota, PharmD, BCPS, BCGP, and Kelly Kroustos, PharmD, CDP, to discuss caring for elderly women.

To celebrate National Pharmacist Day, regonized every year on January 12, Meagan Brown, PharmD, BCACP, discussed the current state of nationally recognizing pharmacists as clinical providers.